For instance, in lung cancer, IGF2BP2 increases the stability of fms-related tyrosine kinase 4 (FLT4; also known as VEGFR3) or thymidine kinase 1 (TK1) mRNA, leading to tumor angiogenesis and aggressiveness [61, 62]. Here, FLT4 is linked to lung carcinoma.